CompletedPhase 3NCT03079167

PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Sydney
Principal Investigator
Helen Liley, BHB, MBChB
University of Sydney
Intervention
Epoetin Alfa(drug)
Enrollment
313 enrolled
Eligibility
All sexes
Timeline
20162024

Study locations (24)

Collaborators

National Health and Medical Research Council, Australia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03079167 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials